Impact of intended and relative dose intensity of R-CHOP in a large, consecutive cohort of elderly diffuse large B-cell lymphoma patients treated with curative intent: no difference in cumulative incidence of relapse comparing patients by age.
Toby Andrew EyreN Martinez-CalleC HildyardD W EyreH PlaschkesJ GriffithJ WolfP FieldsA GunawanR OliverFaouzi DjebbariS BoothA McMillanC P FoxM J BishtonG P CollinsC S R HattonPublished in: Journal of internal medicine (2019)
'R-mini-CHOP' provides adequate lymphoma-specific disease control and represents a reasonable treatment option in elderly patients ≥80 years aiming for cure.